OBJECTIVES: Ischaemia/reperfusion (I/R) injury of the lungs contributes to pulmonary dysfunction after cardiac surgery with cardiopulmonary bypass (CPB), leading to increased morbidity and mortality of patients. This study investigated the value of controlled lung reperfusion strategies on lung ischaemia-reperfusion injury in a porcine CPB model.
INTRODUCTION
Postoperative pulmonary dysfunction is a frequent observation in patients undergoing cardiac surgery with cardiopulmonary bypass (CPB). Symptoms range from subclinical functional changes to severe pulmonary dysfunction with prolonged mechanical ventilation. Approximately 0.5-1% of patients develop an adult respiratory distress syndrome that results in a postoperative mortality rate of over 50% [1] .
The exact underlying pathophysiological mechanisms inducing post-CPB pulmonary dysfunction remain unclear. The CPBrelated inflammatory response and reduction in pulmonary blood flow with transient ischaemia of the lungs have been identified as major contributing factors for postoperative pulmonary complications [2] [3] [4] . During full-flow CPB, the lungs are excluded from the blood circulation because lung perfusion through the bronchial arteries is significantly diminished to avoid sufficiently lung ischaemia [2, 4] . Additionally, temporary interruption or reduction in lung ventilation during full-flow CPB augments lung ischaemia. Importantly, lung injury is not only caused by the CPB-related ischaemic interval, but also further enhanced by the subsequent reperfusion of the ischaemic lung tissue with normal blood (uncontrolled reperfusion, UR), which is commonly also known as ischaemia-reperfusion injury (I/R injury).
The theory of I/R injury postulates that tissue injury seen after ischaemia is not only caused by molecular changes and processes during the ischaemic interval, but also reperfusion of ischaemic tissue allows the induction of further detrimental molecular processes by providing oxygen and neutrophils to susceptible tissue. Mechanisms of I/R injury include neutrophil activation, release of proinflammatory mediators and formation of oxygen radicals, thereby causing oxidative stress with physiological and histological changes in the lungs and deterioration in pulmonary function [5] . Understanding the pivotal role of UR for post-CPB pulmonary injury is of great importance because it might be prevented by implementation of various reperfusion strategies borrowed from cardiac surgery. In cardiac surgery, the main focus is on myocardial protection by optimizing cardioplegic strategies. Recognition of reperfusion injury after ischaemia as a crucial cause for tissue damage resulted in new strategies to prevent I/R injury by developing the concept of 'controlled reperfusion'. 'Controlled reperfusion' means to control the composition of reperfusate and conditions of reperfusion during initial reperfusion after an ischaemic episode. Thereby detrimental effects of reperfusion should be diminished, reducing tissue damage. This concept of 'controlled reperfusion' is partially incorporated in clinical practice for myocardial protection during cardiac surgery with cardioplegic arrest. 'Controlled reperfusion' has been shown to attenuate I/R injury of the heart [6] . 'Controlled reperfusion' is not only limited to a fixed protocol, but also offers multiple modalities to influence initial reperfusion after ischaemia. In experimental models of lung transplantation and isolated lung ischaemia, 'controlled reperfusion' improved post-procedural lung function in contrast to UR with normal, unmodified blood [7] . However, benefit of controlled lung reperfusion before weaning from CPB after cardiac surgery has not yet been investigated. Certainly, it is unclear whether there are thresholds for the full-flow CPB time to cause critical lung ischaemia resulting in lung I/R injury.
The present study investigated the impact of different controlled lung reperfusion strategies in a porcine CPB model simulating cardiac surgery with CPB and their impact on post-CPB cardiac and pulmonary function, inflammation and morphological alteration.
METHODS
The study protocol was approved by the responsible ethical committee for animal care of the University of Cologne (LANUV, Northrhine-Westphalia, Germany) and animals received care in compliance with the Directive 2010/63/EU of the European Parliament.
Experimental protocol
Twenty-five pigs (mast hybrids; body weight 56.1 ± 5.1 kg) were premedicated with azaperone (2 mg/kg i.m.) and ketamine (10 mg/kg i.m.). Neuromuscular blockade was achieved with pancuronium (0.2 mg/kg i.v.). After endotracheal intubation, continuous anaesthesia and analgesia were maintained with propofol (10-15 mg/kg/h i.v.) and buprenorphin (0.8 mg i.v. every 4 h). Animals were ventilated with volume-controlled ventilation (Fabius GS, Dräger, Luebeck, Germany) using an air/oxygen mixture adjusted to keep arterial blood gas values in the normal range (PaO 2 100-150 mmHg, PaCO 2 35-45 mmHg, pH 7.35-7.45). The right jugular vein and carotid artery were dissected and cannulated under sterile conditions for measurements of the central venous pressure (CVP) and the mean arterial pressure (MAP), and for blood sampling. The CVP was kept constant by continuous saline infusion at a rate of 5-10 ml/kg/h. After sternotomy and pericardial incision, the pulmonary artery and left atrial appendage were cannulated for blood sampling and for pulmonary artery (PAP) and left atrial pressure (LAP) measurements. Pressure transducertip catheters (Model SPC-350S, Millar Instruments, Inc., Houston, TX, USA) were placed into the right and left ventricle. Two sonomicrometric piezoelectric crystals 2 mm in diameter (Sonometric Corporation, London, ON, Canada) were implanted along the axis of the right ventricular outflow tract for the assessment of regional right ventricular contractile function, and a mersilene band was wrapped around the inferior vena cava for subsequent measurements of right ventricular pressure-dimension loops. Cardiac output (CO) was recorded by a transit time flow probe (Model 20A, Transonic Systems, Inc., New York, NY, USA) placed around the ascending aorta. Body temperature was measured through a urine catheter and a heating table maintained the body temperature at 37°C throughout the protocol.
Cardiopulmonary bypass management
After systemic anticoagulation (heparin 300 IU/kg; activated clotting time >400 s), the ascending aorta and right atrium were cannulated using standard cannulas. CPB was initiated and a vent was inserted through the LV apex for LV decompression. CPB equipment comprised a roller pump (Stöckert Instruments GmbH, Munich, Germany), a membrane oxygenator (Sorin, Munich, Germany) and an extracorporeal circuit (Medos Medizintechnik, Stolberg, Germany) with standard priming (1000 ml Ringer's lactate, 100 IU/kg heparin and normocalcaemia). Animals were placed on full-flow, normothermic CPB for 120 min with a flow index of 2.5-3.3 l/min/m², and the MAP was kept in the range 50-70 mmHg. After 10 min of CPB, the ascending aorta was clamped and cardioplegic cardiac arrest (CCA) was induced for 60 min using antegrade warm blood cardioplegia (Calafiore protocol with 10 ml of KCl 14.9% and 40 ml of MgSO 4 50%) administered into the aortic root. Simultaneously with aortic clamping, the pulmonary trunk was clamped in all animals undergoing CPB to ensure cessation of pulmonary artery blood flow. Also, mechanical ventilation was switched off during cardioplegic arrest and full-flow CPB. CCA was maintained by reinfusions every 15 min. After aortic unclamping, the heart rhythm was restored when necessary by defibrillation and the myocardium recovered from ischaemia by 20 min of full-flow CPB with an unloaded heart. During this cardiac reperfusion, the pulmonary trunk was still clamped to prevent gradual restoration of pulmonary artery flow. Thus, a standardized interval of 80 min with no pulmonary artery flow was guaranteed in all CPB animals.
Experimental groups
After 20 min of cardiac reperfusion with full-flow CPB and without pulmonary artery blood flow, animals were subdivided into three groups using a random allocation sequence:
In Group 1 (n = 6), the pulmonary artery trunk was unclamped after the above-described 20 min of cardiac reperfusion and mechanical ventilation started again. This previous cardiac reperfusion allowed a rapid increase in cardiac preload and decrease in CPB flow, resulting in cardiac ejection. Cardiac ejection and CPB
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In contrast to the UR group, in Groups 2 and 3 (n = 6 per group), the pulmonary artery trunk remained occluded after 20 min of cardiac reperfusion and animals received controlled lung reperfusion for the following 15 min. In Group 2, reperfusion conditions were controlled (controlled reperfusion group; CR group) by perfusing the lungs via a catheter placed in the common pulmonary artery trunk with normothermic (37°C), normoxic and normocapnic arterial blood (PO 2 100-150 mmHg; pH 7.35-7.45; PCO 2 35-45 mmHg). Arterial blood for reperfusion was taken from the CPB oxygenator. Normoxic and normocapnic conditions were achieved by adjusting oxygenator settings during cardiac reperfusion. Blood conditions were checked by serial blood gas analysis. Controlled reperfusion flow was set via a separate roller pump to 250 ml/min with a pulmonary pressure limitation at 25 mmHg. In Group 3, lung reperfusion conditions were controlled similar to Group 2 except for an additional modification of the reperfusate (modified reperfusion group; MR group). The modified reperfusion solution comprised a commercially available solution (Buckberg cardioplegia 'Hot Shot'; Dr F. Köhler Chemie GmbH, Bensheim, Germany) with hypocalcaemic, hyperosmotic, alcalotic and substrate-enriched properties ( Table 1 ). The normothermic (37°C) reperfusate was applied in a 4 : 1 blood-crystalloid ratio via a roller pump (total flow 250 ml/min). After controlled reperfusion, normal pulmonary artery perfusion was restored and mechanical ventilation started in Groups 2 and 3, and all animals were weaned from CPB after 120 min. Additionally, sham-operated animals (sham group; n = 7) underwent full instrumentation with median sternotomy, but without implementation of CPB. Animals were monitored for 4 h after CPB with the chest being left open until the end of the experimental protocol and, thereafter, euthanized using an intravenous overdose of pentobarbital. After controlled euthanasia, the right lung was immediately fixated (see section 'Quantitative assessment of lung tissue by electron microscopy') and removed.
Haemodynamic and pulmonary measurements
Haemodynamic and pulmonary function measurements were performed during stable haemodynamic and respiratory conditions before CPB (baseline; t1) and 4 h post-CPB (t4). Heart rate, MAP, PAP, CVP, LAP, left ventricular (LV) and right ventricular (RV) pressure and the maximum first derivate (dp/dt max ) and CO were recorded. All data were digitalized at a rate of 500 Hz using a 16-channel haemodynamic set-up and subsequently analysed (Hugo Sachs Elektronik-Harvard apparatus GmbH, MarchHugstetten, Germany). Systemic vascular resistance and pulmonary vascular resistance (PVR) were calculated by using standard equations.
RV pressure-dimension loops were assessed in triplicate during transient occlusion of the inferior vena cava over a total of 12-16 heart beats and apnoea. RV fraction shortening (FS) as a measure of regional RV contractility was calculated as RV-FS = (EDD − ESD)/ EDD, where EDD represents end-diastolic intercrystal distance and ESD, end-systolic intercrystal distance. For load-independent assessment of RV contractility, the preload recruitable stroke work (PRSW) [8] was calculated using a commercially available software package (Cardiosoft, Sonometric Corporation).
Volume-controlled ventilator settings were adapted to predefined conditions [inspiratory oxygen fraction (FiO 2 ) 0.5, positive end-expiratory pressure, 5 cmH 2 O, I/E ratio 12, respiratory rate 14/min, tidal volume 12 ml/kg] 15 min before each measurement to allow comparability of lung function between time points. Inspiratory pressures (P peak and P plateau ) were recorded and arterial and mixed venous blood gas analysis was performed. Static and dynamic lung compliance (LC), oxygenation index (PaO 2 /FiO 2 ), alveolar-arterial oxygen gradient (AaDO 2 ) and pulmonary shunt were calculated using standard formulas [9] ( Table 2) .
Biochemical analysis
Serial blood samples were obtained at t1, t2 (direct after CPB) and t4 from the left atrium for determination of markers of pulmonary inflammation (interleukin-6, IL-6) and endothelial damage (endothelin-1, ET-1). After centrifugation for 10 min at 2000 rpm, plasma was separated and stored at −80°C until assay. Blood samples were analysed using commercially available kits according to the manufacturer's recommendations (Porcine IL-6 and ET-1 
Lung oedema
Lung tissue samples (apical and basal part of the left lung) were obtained from t1 and t4 and weighed (wet weight) and then freeze-dried after lyophilization. Dry weights were measured after incubation of specimens at 110°C for 2 days and corrected for residual water content. Lung oedema was calculated by using the formula: % tissue water = (wet weight − dry weight) wet weight, and expressed as a percentage of the wet weight. All measurements were performed in duplicate and the average was taken to balance the influence of hydrostatic distribution, venti-lation and perfusion on the lung tissue water content.
Quantitative assessment of lung tissue by electron microscopy
Immediately post-mortem (t4), the right lung was perfused with a fixative containing 4% paraformaldehyde and 0.1% glutaraldehyde in 0.2 M HEPES buffer as previously described [10] . After volume estimation, the lungs were sampled using a systematic uniform protocol and tissue samples randomly processed for light or electron microscopy by post-fixation in osmium tetroxide, en bloc staining in uranyl acetate, dehydration in an ascending ethanol series and finally embedding in glycol methacrylate or epoxy resin. Sections were generated using a rotational microtome or an ultramicrotome and stained with toluidine blue or lead citrate and uranyl acetate. Using design-based stereological methods, the volume of extravasated, intra-alveolar oedema fluid and red blood cells as well as the damage of the blood-air barrier were evaluated quantitatively as described previously [11] . In short, the volume of intra-alveolar oedema and red blood cells was estimated by the point counting method at the light microscopic level. The integrity of the blood-air barrier was evaluated with a transmission electron microscope (EM902, Zeiss, Oberkochen) and the relative surface area of a normal, swollen or fragmented blood-air barrier was estimated. The different integrity states were assigned the number 1 for normal, number 2 for swollen and number 3 for fragmented to calculate a blood-air barrier index that increases with increase in damage of the blood-air barrier.
Statistical analysis
Statistical analysis was performed using the SPSS statistical software package (Version 18; IBM, Armonk, NY, USA). Continuous parameters are given as means ± standard deviation (SD). Changes in comparison with baseline values of continuous variables within individual treatment groups were analysed by the paired t-test.
For analysis between groups, data were normalized to baseline values and compared by a one-way ANOVA with the post hoc Fisher LSD test. A P-value of <0.05 was considered to be statistically significant.
RESULTS
Haemodynamic parameters, pulmonary function and lung oedema
In animals of the sham group not undergoing CPB, haemodynamic parameters remained constant throughout the experiment. Only maximal RV dp/dt decreased but without changes in other parameters of RV function. Lung mechanics decreased slightly in this group with a significant decrease in dynamic LC but no significant deterioration in static LC. Other parameters of pulmonary function were constant compared with baseline values, whereas the water content in lung tissue increased during the experimental course (Table 3) . However, in the UR group, pulmonary function was impaired significantly after CPB. Lung mechanics (P peak , static LC and dynamic LC) and the oxygenation index decreased, whereas AaDO 2 and lung tissue water content increased. Only for the pulmonary shunt fraction, the increase was not so distinct as to reach the statistical significance level. Deterioration of pulmonary function was accompanied by elevation in the PVR and a reduction in RV function (significant decrease of RV-FS; P = 0.038, not significant decrease of RV PRSW; P = 0.147). Other haemodynamic parameters remained constant with the exception of an increased CVP post-CPB (Table 3) .
Both groups undergoing controlled lung reperfusion strategies (CR and MR) presented a worsening of lung mechanics and an increase in the lung tissue water content after CPB. However, pulmonary dysfunction was less pronounced, without deterioration of oxygenation index and AaDO 2 (Table 3) . Furthermore, intergroup analysis revealed no significant differences between the sham group and both lung reperfusion strategies (CR and MR), but a significant decline in lung mechanics for the UR group compared with all other groups. Only for lung oedema elevation in the lung tissue water content was significantly higher in all CPB groups, compared with the sham group (Fig. 1) .
In the CR group, the haemodynamic changes were similar to the UR group with an increase in PVR and a decrease in RV-FS. In the MR group, an increase in right ventricular contractility (RV PRSW) and higher CVP resulted in a significant rise in CO after CPB (Table 3 ). This improvement in right ventricular function in the MR group was in contrast to all other groups and was followed by a significantly higher CO in comparison with all other groups (Fig. 2) .
ELISA and thiobarbituric acid reactive substance
Compared with baseline values, ET-1 remained unchanged throughout the protocol in sham-operated animals. IL-6 blood concentration increased slightly during the experimental course without CPB, resulting in significantly higher levels at t4 compared with the baseline. However, in all CPB groups, ET-1 and IL-6 blood concentration increased during CPB with significantly elevated levels post-CPB (ET-1 t2: UR 148 ± 50%*; CR 179 ± 57%*; MR 195 ± 100%*; IL-6 t2: UR 1434 ± 1118%*; CR 4382 ± 4195%*; MR 5443 ± 5120%*; *P <0.05 compared with baseline t1) followed by a decrease during the further experimental course. ET-1 in all CPB groups (UR, CR and MR) decreased towards baseline values, resulting in no significant differences at 4 h post-CPB (t4) compared with the baseline (t1). However, intergroup analysis at t4 resulted in significantly elevated ET-1 levels in both controlled reperfusion groups (CR and MR), compared with the sham group. By contrast, IL-6 remained significantly elevated at 4 h post-CPB (t4) compared with pre-CPB values (t1) in all CPB groups, but only the MR group had significantly elevated IL-6 levels compared with all other groups, whereas the UR and CR groups revealed no significant differences compared with sham-operated animals at t4 (Table 4) . Concentration of endothelin-1 (ET-1) and interleukin-6 (IL-6) in left atrial blood at baseline (t1) and at 4 h post-CPB and 6 h post-baseline, respectively, for the sham group (t4). Data are given as mean ± SD. $ P <0.05 compared with the baseline (intragroup analysis). # P <0.05 compared with all groups. § P <0.05 compared with the sham group.
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MDA concentration measured by TBARS assay in left atrial blood decreased during the experimental protocol in shamoperated animals with a significant reduction at the end of experiment (t4), compared with baseline values (t1). In the UR and MR group, MDA increased on CPB with elevated levels directly after CPB (t2: UR 151 ± 50%*; CR 103 ± 14%; MR 198 ± 62%*; *P <0.05 compared with baseline t1), whereas MDA remained unchanged in the CR group. In all CPB groups, the MDA concentration decreased in the further experimental course. Finally, at 4 h post-CPB (t4), MDA levels showed no significant changes to pre-CPB in all CPB groups, and intergroup analysis revealed no differences between groups, even in comparison with the sham group (Table 4) .
After calculating the pulmonary gradient for MDA (MDA pulmo = MDA left atrial − MDA pulmonary artery ), there were no differences between all groups at baseline (t1) with the pulmonary gradient tending to zero (sham 0.1 ± 2.0; UR −0.1 ± 3.6; CR 1.5 ± −2.8; MR 0.0 ± 4.1). Although immediately after CPB (t2) intragroup and intergroup (one-way ANOVA P = 0.251) differences were not significant, MDA pulmo of the UR group was increased 4 h after CPB (t4) compared with all other groups (sham −1.1 ± 1.0; UR 5.4 ± 5.1; CR −2.4 ± 2.8; MR 0.2 ± 5.4). MDA pulmo for the CR and MR groups were not significantly different from the sham-operated animal group (Fig. 3) . In these groups (sham, CR and MR), negative values or values tending to zero indicated no increased formation of MDA in the lung in contrast to the UR group, in which we recorded a significantly higher formation of MDA in the lung.
Quantitative assessment of lung tissue
The damage of the blood-air barrier was similar in all CPB groups with an integrity index above 1.5 for all groups at the end of the protocol. Swollen epithelium contributed to the largest surface area fraction with only rare occurrence of fragmented cells. Both intra-alveolar oedema fluid and intra-alveolar red blood cells were rarely observed in all experimental CPB groups, with less than 1% of volume fraction in all CPB groups (Fig. 4) . In conclusion, there were no differences in lung damage assessed by electron microscopy between intervention groups.
DISCUSSION
Postoperative pulmonary dysfunction after CPB in cardiac surgery is a major issue in postoperative care. Various factors are responsible for occurrence of pulmonary dysfunction, but CPB contributes significantly to this clinical problem. The results of the present experimental series emphasize the clinical problem of postoperative pulmonary dysfunction after cardiac surgery with the use of CPB [1, 3, 12, 13] . To distinguish between directly CPB-related and non-CPB-related factors (i.e. sternotomy, pleural space opening and mechanical ventilation) contributing to pulmonary dysfunction after cardiac surgery, our model included a sham-operated group of animals. Despite the absence of CPB, distinct deterioration in lung mechanics (P peak , dynamic LC and static LC) and an increase in lung tissue oedema throughout the 6-h experimental protocol could be observed in the sham group, which can be attributed to surgical trauma and mechanical ventilation. The latter is known to influence pulmonary function in the clinical setting and can be frequently observed after off-pump cardiac surgery [14, 15] . Importantly, no significant deterioration in other pulmonary function variables or haemodynamics were noted in the sham group. Additionally, biochemical assessment of blood samples from the left atrium showed no increase in markers of oxidative stress (MDA) or endothelial injury (ET-1), with a significant increase in inflammation (IL-6), but altogether these results excluded the presence of a deleterious inflammatory reaction or ischaemia in the sham group. These observations are in agreement with previous clinical reports of patients undergoing offpump CABG, where the inflammatory response was shown to be attenuated compared with patients operated on-pump [16] .
The use of CPB in cardiac surgery is known to augment injury of the lungs by two interrelated mechanisms termed systemic inflammatory response (SIRS) and lung I/R injury [2] [3] [4] that can result in high morbidity and mortality of patients [1] . In our experimental model, these changes are reflected by a significant impairment of post-CPB pulmonary function variables, including higher inspiratory pressures (P peak ) and lung oedema, loss of dynamic and static LC that resulted in a deterioration of oxygenation, PVR and AaDO 2 . The functional pulmonary alterations were mostly pronounced in the UR group and associated with a significant post-CPB increase in IL-6, MDA and ET-1 in left atrial blood, suggesting the involvement of CPB-related inflammation, oxidative stress and endothelial injury. Similar to our used model, in previous experimental series, the use of CPB has been shown to decrease pulmonary and bronchial arterial blood flow to the lungs [4] . Experimental and clinical studies in which pulmonary artery perfusion was continued during CPB resulted in substantial attenuation of lung injury [2, [17] [18] [19] . However, use of these techniques, including continuous pulmonary artery perfusion or the Drew-Anderson technique, is technically challenging and often interferes with the main surgical procedure; hence they are rejected by most cardiac surgeons.
Importantly, the duration of lung ischaemia during full-flow CPB makes the involved pulmonary tissue more susceptible to the following reperfusion sequence when pulmonary artery perfusion is re-established in an uncontrolled manner with unmodified blood before weaning from CPB (i.e. reperfusion injury) [5] . Consequently, some strategies of controlled lung reperfusion have shown promising results by reducing lung I/R injury and underline the importance of the first minutes of reperfusion for manifestation of lung I/R injury [7] . The concept of controlled reperfusion with modified blood after an ischaemic interval is widely used for myocardial protection in cardiac surgery every day (so-called hot-shot) [6] and has been implemented in other organs, including human lung transplants, with excellent results of post-transplant lung function [20, 21] . However, experience with controlled lung reperfusion strategies during routine CPB for avoidance of postoperative lung dysfunction is very limited and restricted to experimental animal models. Additionally, there is lack of information about thresholds for full-flow CPB time inducing critical lung ischaemia with subsequent lung I/R injury. However, it is obvious that patients undergoing very long full-flow CPB would benefit most from controlled reperfusion to attenuate lung I/R injury. Especially in patients with complex cardiac surgical procedures as redo surgery or combined procedures necessitating long CPB support, controlled lung reperfusion could be a treatment option to attenuate lung damage and avoid postoperative lung failure.
In our experimental work, we investigated two different strategies of controlled lung reperfusion. In a first step (CR group), we controlled solely the reperfusion conditions of the lungs (blood flow, temperature, perfusion pressure and blood oxygenation) to counteract pulmonary oxidative and endothelial injury from hyperaemia, hypertension and hyperoxaemia [6, 7] . In the next step, we additionally modified the blood reperfusion solution (MR group, see Table 1 ) by applying known principles from cardiac surgery [6] to counteract hypercalcaemia, lung oedema and tissue acidosis, and provide a substrate-enriched perfusate [6, 7] . Nonetheless, beyond significant improvements in lung mechanics (static LC, dynamic LC and peak inspiratory pressure) in both controlled reperfusion groups compared with UR, no other benefits could be observed post-CPB in terms of a preserved lung morphology (electron microscopy) or improved oxygenation index. However, it should be considered that the inflammatory process following I/R injury resulting in pulmonary dysfunction is not finished 4 h after CPB. Rather, some functional changes emerge delayed as an effect of inflammation. Clinical experience showed that lung mechanics decrease within 4 h after cardiac surgery, whereas changes in gas exchange parameters occur delayed within 24 h postoperatively [1] . This could explain why improvement in lung function was limited to lung mechanics in our experiment, whereas parameters of gas exchange were equal, possibly necessitating follow-up longer than 4 h post-CPB for adequate evaluation. Similarly, although the transpulmonary gradient of MDA was significantly reduced in both controlled reperfusion groups compared with the UR group, no significant difference could be detected for IL-6 and ET-1. Thus, despite improvement in lung mechanics, the strategy of controlled lung reperfusion failed to avoid substantially post-CPB pulmonary dysfunction and to influence endothelial injury, inflammation and morphological lung damage.
Various limiting factors may have influenced the results of our experimental model. First, the use of additional strategies of modifying the reperfusate such as a white blood cell filter for leucocyte depletion may have led to a significant attenuation of the inflammatory response and improved pulmonary function in our model. In previous work, leucocyte depletion resulted in an additional protection against lung I/R injury [7] and attenuated inflammation in a previous study by Kagawa et al. [22] . Thus, the reduction in pulmonary inflammation could enhance the benefit of controlled lung reperfusion. Second, the use of normoxic arterial blood for controlled lung reperfusion, as used in our model and most previous experimental studies [7, 18, 19] , may have largely influenced our results. Recently, it was shown that hypoxaemic lung reperfusion was advantageous over hyperoxaemic lung reperfusion [22] . The possible underlying mechanism is an increased formation of reactive oxygen species during reperfusion with hyperoxaemic blood as a fundamental mechanism of lung I/R injury [5, 23] . Thus, further reduction of blood oxygenation in the reperfusate below normoxia, even to venous blood levels, may augment the results of controlled reperfusion. Third, endothelial injury indicated by elevated ET-1 post-CPB in all controlled reperfusion groups underlines the need for a more rigorous pressure control of the reperfusion strategy. ET-1 is released from the pulmonary vasculature during CPB because of ischaemia-reperfusion with subsequent endothelial injury and acts as a strong vasoconstrictor, leading to increased PVR and inflammation [24] . In our CPB animals with controlled reperfusion, a significant elevation of ET-1 concentration was noted compared with the sham and the UR group, indicating increased endothelial injury. Although we applied a strict perfusion pressure limitation of 25 mmHg in controlled reperfusion animals, this might have been too high. Consequently, a significant attenuation of lung dysfunction and endothelial injury was observed in an experimental model after applying a perfusion pressure limit to 5 mmHg during controlled lung reperfusion [25] .
Furthermore, beyond optimizing controlled reperfusion conditions, it appears also important to define which patients may benefit from a controlled lung reperfusion strategy during CPB. Beyond individual risk factors and pre-existing lung disease, the exact duration of full-flow CPB for a clinically relevant lung injury remains unknown. In our model, we used 60 min of CCA followed by 20 min of cardiac reperfusion with full-flow CPB, thereby closely reflecting a routine cardiac procedure with fullflow CPB. Others have used longer durations of full-flow CPB with up to 180 min of reduced lung perfusion that may partially explain the extent of observed lung injury among these studies [18, 19, 22] . Thus, further studies are necessary to determine the critical time threshold of full-flow CPB for lung injury and to define the optimal reperfusion modalities to prevent post-CPB lung dysfunction.
CONCLUSION
Controlled lung reperfusion in our model of a standard cardiac surgical procedure failed to avoid lung dysfunction related to CPB. Only a few parameters to assess pulmonary function were slightly improved by controlled reperfusion. This indicated no benefit of controlled lung reperfusion in standard cardiac surgical procedures. Still, there is the assumption for controlled lung reperfusion to be advantageous in high-risk scenarios of postoperative pulmonary dysfunction with extensive surgical procedures and increased CPB duration. 
